Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why the Dow's Feeling Happy This Morning

Wall Street often focuses on esoteric indicators that most people can't relate to at all. But once a month, the market turns its attention to something near and dear to everyone's hearts: employment. This morning's report showing that nonfarm payrolls rose by 146,000 jobs beat economists' expectations, as the unemployment rate inched down to 7.7%. A poor report on consumer confidence dampened the enthusiasm somewhat, but at 10:45 a.m. EST, the Dow Jones Industrials (DJINDICES: ^DJI  ) remained higher by about 34 points, even as the broader market sagged slightly.

Among Dow stocks, JPMorgan Chase (NYSE: JPM  ) led the risers, up almost 2%. Reports citing bank executives say JPMorgan's investment bank may see its bonus pool fall by 2%. That may be bad news for workers there, but it's a much better result than the 10% drop some Citigroup (NYSE: C  ) workers may see. With JPMorgan expanding in areas with strong growth potential, it could well continue to outperform many of its peers.

But on the downside, Verizon (NYSE: VZ  ) fell nearly 1%. T-Mobile has made big waves in the industry in recent days, not only announcing a deal that could enable it to offer iPhones to its customers, but also saying it will stop subsidizing smartphones. The move may eventually lead Verizon to follow suit, but given how subsidies have done a great job of locking customers into long-term contracts that support the company's profits, the pricing adjustments that Verizon may have to make to its service plans could require a big adjustment in profit expectations.

Finally, Pfizer (NYSE: PFE  ) also dropped by about 1%. Yesterday, the U.K.'s National Institute for Health and Clinical Excellence, which advises the nation's state-run health care service on the cost-benefit analysis of drugs, gave a preliminary decision against Pfizer's Inlyta treatment for advanced kidney cancer. With a price of roughly $100 per 5-milligram tablet, Pfizer offered the health service a discount, but that failed to win regulators over. The move shows how gaining regulatory approval to sell  a drug doesn't guarantee success if a company can't get reimbursement for it.

Are big banks riding high?
Big financial institutions are an important part of the Dow, but should they be in your portfolio? There's a big divide in the industry, with JPMorgan having recovered most of its lost ground from the 2008 bear market while others continue to languish. But is JPMorgan still a buy today? Find out by reading our premium research report on the company today. Click here now for instant access!

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2144272, ~/Articles/ArticleHandler.aspx, 10/28/2016 10:14:13 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,209.01 39.33 0.22%
S&P 500 2,133.41 0.37 0.02%
NASD 5,218.65 2.68 0.05%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/28/2016 9:56 AM
C $49.75 Down -0.18 -0.36%
Citigroup CAPS Rating: ***
JPM $69.23 Down +0.00 +0.00%
JPMorgan Chase CAPS Rating: ****
PFE $32.23 Down -0.25 -0.77%
Pfizer CAPS Rating: ****
VZ $48.29 Down -0.25 -0.52%
Verizon Communicat… CAPS Rating: ****